HOME > BUSINESS > Article

Text Size

small

medium

large


AnGes Starts Japan's 1st Clinical Trial of COVID-19 Vaccine

AnGes Starts Japan's 1st Clinical Trial of COVID-19 Vaccine

   Osaka, June 30 (Jiji Press)--Japanese pharmaceutical startup AnGes Inc. said Tuesday that it has started a clinical trial of a potential vaccine for COVID-19.
   The clinical trial, the first in Japan for the coronavirus disease, will be participated in by 30 healthy adults at Osaka City University Hospital.

To read a full story, please click here to find out how to subscribe.

BUSINESS

Aomori Tourism Information

HEADLINES

POLITICS
Toyama Governor Race to Kick Off on Oct. 8 for Voting on Oct. 25
ECONOMY
Tokyo Area Condo Supply in 2020 1st Half Drops 44% to Record Low of 7,497 Units
SPORTS
Gymnastics Women: Teramoto Steadily Recovering from Achilles Tendon Rupture
OTHER
Haneko Takayama, Haruka Tono Each Win Akutagawa Prize, Seishu Hase Naoki Prize

AFP-JIJI PRESS NEWS JOURNAL


Photos